Tg Therapeutics Inc (TGTX)

EBITDA Margin

9.06%

Quarterly · Period ending:

TGTX logo

TGTX EBITDA Margin

Latest reported9.06%
TGTX Quarterly EBITDA Margin (100.00% → 9.06%)
High-resolution chart · PNG

TGTX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
9.0582%
13.7172%
26.8432%
20.2166%
26.706%
10.1617%
30.1114%
18.0784%
14.4284%
-13.0888%
-26.1604%
71.0243%
-273.0994%
-464.7828%
-62,507.5%
-36,213.8298%
-6,289.899%
-3,284.7222%
-3,969.2374%
-4,161.0837%
-4,967.8317%
-11,175.0315%
-228,476.3158%
-224,892.1053%
-133,068.4211%
-131,134.2105%
-98,947.3684%
-158,739.4737%
-92,402.6316%
-90,418.4211%
-142,436.8421%
-89,284.2105%
-116,107.8947%
-109,360.5263%
-81,414.8838%
-82,853.8429%
-74,560.966%
-72,571.2036%
-61,536.3329%
-65,377.7982%
-42,017.3356%
-36,712.8915%
-46,291.8362%
-35,187.0748%
-44,240.1129%
-38,326.3735%
-49,139.3805%
-45,775.0157%
-31,381.1393%
-19,215.653%
-13,591.4766%
-11,327.5409%
-17,400.1076%
-9,035.3695%
-13,575.0315%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
4,533.15%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-49.7598%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.